SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-18-008712
Filing Date
2018-07-03
Accepted
2018-07-03 16:40:51
Documents
2
Period of Report
2018-06-29

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3497
2 POWER OF ATTORNEY f4062918ex24icranston_delmar.htm EX-24 6029
  Complete submission text file 0001213900-18-008712.txt   10931
Mailing Address SUITE 720-999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720-999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (604) 629-5989
DelMar Pharmaceuticals, Inc. (Issuer) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4316 LOCARNO CRESCENT VANCOUVER A1 V6R 1G3
Business Address
Cranston Lynda Sarah (Reporting) CIK: 0001633660 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37823 | Film No.: 18937938